News

Count yourself lucky if you haven't been a Tilray shareholder over the past five years. It's nice that Tilray is diversified, ...
Tilray Brands is down a lot in 2025 and since its IPO, but it has rallied substantially from its April all-time low. Read why ...
We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Tilray Brands, Inc. is placed first ...
Tilray's fiscal Q4 results disappointed, with revenues missing estimates and a massive $1.26B net loss driven by impairment ...
Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...
Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.
Live Updates Live Coverage Has Ended CEO on Conference Call 5:06 pm Updates from CEO Irwin Simon on tonight’s call: ...
Tilray Brands Inc. closed 72.47% short of its 52-week high of $2.11, which the company reached on August 1st.
Tilray ended fiscal 2025 with record revenue of $821 million, driven by its cannabis, beverage, and wellness divisions. The company remains Canada's top cannabis brand and saw international cannabis ...
Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 2.3% ...
Shares of Tilray are trading lower Tuesday morning. The company reported Q4 revenue that fell short of analyst expectations.
Alliance Global Partners cut its price target on Tilray Brands ( TLRY 15.87%) stock by 25% this morning, from $1 to just ...